We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$3.77B
AUM Growth
+$170M
Cap. Flow
+$54.5M
Cap. Flow %
1.45%
Top 10 Hldgs %
33.11%
Holding
341
New
28
Increased
122
Reduced
88
Closed
23

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$16.7M
2
VRT icon
Vertiv
VRT
+$11.2M
3
PRCT icon
Procept Biorobotics
PRCT
+$9.99M
4
LLY icon
Eli Lilly
LLY
+$9.7M
5
MSFT icon
Microsoft
MSFT
+$5.89M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$5.86M
2
AAPL icon
Apple
AAPL
+$3.39M
3
ALIT icon
Alight
ALIT
+$3.37M
4
IDXX icon
Idexx Laboratories
IDXX
+$3.24M
5
ANET icon
Arista Networks
ANET
+$1.76M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 17.25%
3 Communication Services 14.23%
4 Financials 12.77%
5 Consumer Discretionary 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
276
Palo Alto Networks
PANW
$270B
$293K 0.01%
+1,611
New +$304K
MS icon
277
Morgan Stanley
MS
$331B
$291K 0.01%
+2,317
New +$285K
TECH icon
278
Bio-Techne
TECH
$11.2B
$288K 0.01%
4,000
SHEL icon
279
Shell
SHEL
$254B
$286K 0.01%
4,560
-2,104
-32% -$138K
VGT icon
280
Vanguard Information Technology ETF
VGT
$139B
$283K 0.01%
3,640
EQIX icon
281
Equinix
EQIX
$101B
$283K 0.01%
300
AZN icon
282
AstraZeneca
AZN
$263B
$281K 0.01%
2,146
-757
-26% -$106K
NEO icon
283
NeoGenomics
NEO
$1.96B
$270K 0.01%
+16,380
New +$254K
NTIC icon
284
Northern Technologies International Corp
NTIC
$76.2M
$270K 0.01%
20,000
-7,430
-27% -$98K
SONY icon
285
Sony
SONY
$137B
$267K 0.01%
12,615
-130
-1% -$2.53K
BALL icon
286
Ball Corp
BALL
$17.3B
$265K 0.01%
4,800
KTOS icon
287
Kratos Defense & Security Solutions
KTOS
$8.74B
$264K 0.01%
10,000
MDXG icon
288
MiMedx Group
MDXG
$602M
$263K 0.01%
27,390
-130,000
-83% -$1.01M
STRL icon
289
Sterling Infrastructure
STRL
$18.3B
$262K 0.01%
1,558
CEG icon
290
Constellation Energy
CEG
$93.8B
$259K 0.01%
1,159
CBOE icon
291
Cboe Global Markets
CBOE
$32.5B
$251K 0.01%
1,284
GSK icon
292
GSK
GSK
$104B
$250K 0.01%
7,387
+100
+1% +$3.6K
DFAC icon
293
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
$248K 0.01%
7,167
CTVA icon
294
Corteva
CTVA
$52.6B
$245K 0.01%
4,297
DD icon
295
DuPont de Nemours
DD
$18.5B
$243K 0.01%
2,537
-23
-0.9% -$2.39K
EBAY icon
296
eBay
EBAY
$50.6B
$237K 0.01%
3,828
JANX icon
297
Janux Therapeutics
JANX
$925M
$230K 0.01%
+4,300
New +$227K
XLF icon
298
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$229K 0.01%
4,739
SCHF icon
299
Schwab International Equity ETF
SCHF
$66.6B
$227K 0.01%
+12,244
New +$239K
VTV icon
300
Vanguard Morningstar Value ETF
VTV
$188B
$225K 0.01%
1,327
+26
+2% +$4.56K

Similar funds

Chicago Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Chicago Capital held 341 positions worth $3.77B, up 4.7% from $3.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q4 2024 filing shows 28 new, 122 increased, 88 reduced and 23 closed positions. Its largest new stake was lululemon athletica: 4,106 shares worth $1.57M. The largest sale was Edwards Lifesciences, an estimated $5.86M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q4 2024 buy was lululemon athletica: 4,106 shares worth $1.57M.
  • Chicago Capital added most to Boston Scientific in Q4 2024, an estimated $16.7M increase.
  • Chicago Capital's biggest Q4 2024 reduction was Edwards Lifesciences, cutting an estimated $5.86M.
  • Chicago Capital fully exited Alight in Q4 2024, selling an estimated $3.37M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.77B portfolio in Q4 2024.
  • Chicago Capital opened 28 new positions and closed 23 in Q4 2024.
  • Chicago Capital's portfolio value rose 4.7% quarter-over-quarter to $3.77B.

Based on Chicago Capital's 13F filing for Q4 2024, filed 24 Jan 2025.